- Trastuzumab deruxtecan as standard of care for second-line treatment of metastatic HER2-positive breast cancer2023 | First Faculty of Medicine
- Immunotherapy for Bladder Cancer2017 | First Faculty of Medicine
- Guidelines of the Czech Society of Hepatology for diagnosis and treatment of primary biliary cholangitis2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- New developments in the management of gastrointestinal stromal tumour.2011 | First Faculty of Medicine
- Treatment of HER2-positive breast cancer in 20202020 | First Faculty of Medicine
- Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis2020 | Faculty of Medicine in Hradec Králové